Takeda's QDENGA has been approved for people aged 4–60, offering a new prevention tool as dengue cases and the wider disease burden remain a public health challenge.
<iframe src="https://hindustansphere.com/embed/cluster/af30e81d9d6e137d1b1290c00847aa9fb6f71319" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="India approves first dengue vaccine amid rising disease burden"></iframe>
Takeda's QDENGA has been approved for people aged 4–60, offering a new prevention tool as dengue cases and the wider disease burden remain a public health challenge.
